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In Brief
Hosts have many defenses that protect
against parasites. In nature, two distinct
defense strategies are found: constitutive
defenses (always active) and inducible
defenses (triggered by parasites). Here,
Westra et al. show that parasite exposure
drives the evolution of these two distinct
strategies.
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In the face of infectious disease, organisms evolved a
range of defense mechanisms, with a clear distinc-
tion between those that are constitutive (always
active) and those that are inducible (elicited by para-
sites) [1]. Both defense strategies have evolved from
each other [2], but we lack an understanding of the
conditions that favor one strategy over the other.
While it is hard to generalize about their degree of
protection, it is possible to make generalizations
about their associated fitness costs, which are
commonly detected [3–5]. By definition, constitutive
defenses are always ‘‘on,’’ and are therefore associ-
ated with a fixed cost, independent of parasite expo-
sure [4, 5]. Inducible defenses, on the other hand,
may lack costs in the absence of parasites but
become costly when defense is elicited [6] through
processes such as immunopathology [7]. Bacteria
can evolve constitutive defense against phage by
modification/masking of surface receptors [8, 9],
which is often associated with reduced fitness in
the absence of phage [10]. Bacteria can also evolve
inducible defense using the CRISPR-Cas (clustered
regularly interspaced short palindromic repeat,
CRISPR associated) immune system [11], which is
typically elicited upon infection [12–14]. CRISPR-
Cas functions by integrating phage sequences into
CRISPR loci on the host genome [15]. Upon re-infec-
tion, CRISPR transcripts guide cleavage of phage
genomes [16–20]. In nature, both mechanisms are
important [21, 22]. Using a general theoretical
model and experimental evolution, we tease apart
the mechanism that drives their evolution and show
that infection risk determines the relative investment
in the two arms of defense.
RESULTS AND DISCUSSION
To examine factors that can explain the relative investment in
constitutive and inducible defenses, we constructed a mathe-Current Biology 25, 104matical model of hosts and obligately killing parasites that
incorporates the evolution of immunity and epidemiology. Our
model relies on two assumptions concerning the costs asso-
ciated with immunity: (1) constitutive defense is associated
with a fixed (constitutive) cost that is independent of parasite
levels and (2) inducible defense is associated with an infection-
induced cost that increases with increasing frequencies of
infection. This is incorporated in our model as follows: constitu-
tive defense prevents infection and comes with a constitutive
cost such that high defense reduces host birth rate. Inducible
defense increases recovery rate and involves an induced immu-
nopathological cost such that increased defense increases
death rate.
First, we investigated how resource availability affects the
relative investment in constitutive and inducible defenses.
Resource availability is an ecologically relevant factor that,
among a range of possible effects, impacts population density,
which in turn impacts parasite abundance. Evolutionary analysis
(see the Supplemental Experimental Procedures) clearly shows
that constitutive defense is selected for in high resource environ-
ments, whereas inducible defense is favored at low resources
(Figure 1A). We hypothesize that this effect emerges from
the epidemiology of the system with more infections under
nutrient-rich conditions, which leads to higher emergent costs
to inducible defenses. As such, our model, along with pre-
dictions of more specific previous theory [23, 24], suggests
that infection risk may be a general mechanism that determines
the relative investment in constitutive and inducible defense.
We tested this theoretical prediction using bacteria and their
phages. As a model system we used Pseudomonas aeruginosa
PA14, which has a type I-F CRISPR-Cas (clustered regularly
interspaced short palindromic repeat, CRISPR associated)
system (Figure S1A) [25], and phage DMS3vir [26], a mu-like
phage [27]. First, we examined the evolution of bacteriophage
immunity mechanisms under high- and low-resource conditions.
We challenged wild-type (WT) P. aeruginosa PA14 with 104
plaque-forming units (pfu) NTf (non-targeted phage; DMS3vir),
which is not a priori targeted by the WT type I-F CRISPR-Cas
system [26]. In agreement with the theoretical model, bacteria
primarily evolved immunity by loss of the phage receptor (loss
of the pilus; surface modification [sm]) in nutrient-rich medium
(LB) at 3 days post-infection (dpi) but evolved immunity by
CRISPR-Cas in nutrient-limited medium (M9 supplemented
with 0.2% glucose) (Figure 1B).3–1049, April 20, 2015 ª2015 Elsevier Ltd All rights reserved 1043
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Figure 1. Resource Availability Determines
the Evolution of Constitutive and Inducible
Defenses
(A) High resources (low q) select for high con-
stitutive defense, whereas poorer resources
select for lower constitutive and higher inducible
defense.
(B) Fraction of WT that acquired sm-mediated
immunity and CRISPR-Cas-mediated immunity at
3 dpi with 104 pfu NTf (n = 6 in all treatments).
Error bars correspond to 95%confidence intervals
(CIs). Bacteria were grown in LB (high resources)
or M9 (low resources).
See also Figure S1.To formally check for CRISPR-mediated immunity, we
sequenced both CRISPR loci (CRISPR1 and CRISPR2) of 144
independent WT clones that were infected in nutrient-limited
medium with 104 pfu NTf and that were isolated at 3 and 7 dpi
(from six replicate experiments). CRISPR2 was more active than
CRISPR1 (Figures 2A–2C) and the number of acquired spacers
increased over time (Figure 2C). Mapping of novel spacers onto
the phage genome revealed clustering of protospacers around
position 28,000 on the phage genome. Protospacers upstream
and downstream of this position were typically located on the
positive and negative strand, respectively (Figure 2D), a typical
feature of primed spacer acquisition in type I-F CRISPR-Cas
systems [28] that most likely resulted from the partial match
between spacer 1 of CRISPR2 and gene 42 (position 27,616–
28,572) on the phage genome [29]. Sequence analysis showed
that nearly all acquired spacers were unique (97.2% ± 2.5% at
3 dpi and 97.9% ± 3.1% at 7 dpi; Table S1). In agreement
with earlier studies [30], protospacers were invariably flanked
by a GG protospacer-adjacent motif (PAM) (Figure 2E). PAM
sequences play an important role both in spacer acquisition
[31, 32] and in the interference stage of the immune response
[33]. These data corroborate previously reported molecular fea-
tures of acquired immunity by type I-F CRISPR-Cas systems.
Our model suggests that differential phage exposure might be
the driver of investment into constitutive versus inducible immu-
nity; hence, we examined bacterial and phage population den-
sities in the two types of growth media. In M9, bacteria reached
10-fold lower densities compared to LB in the absence of phage
(Figure S1B) and had longer generation times (57 ± 6 min in M9
versus 28 ± 2 min in LB). Furthermore, phage accumulation was
slower inM9 compared to LB, and phage densities were approx-
imately 100-fold lower throughout the measurements (Fig-
ure S1C). Lower host and parasite densities reduce the infection
risk (determined by the product of their densities; see the Sup-
plemental Experimental Procedures). When we varied parasite
production (burst size) in our model, we found that higher para-
site production selected for constitutive defense (Figure S1D),
which further indicated that infection risk may drive the evolution
of the immune strategies.
To experimentally verify that CRISPR-Cas and sm-mediated
immunity indeed results from different phage exposures (and1044 Current Biology 25, 1043–1049, April 20, 2015 ª2015 Elsevier Ltd All rights reservednot from other differences between the
LB and M9 growth media), we increased
phage exposure in M9. Strikingly, agradual increase in phage exposure from 104 to 107 and 109
pfu NTf was associated with decreased evolution of CRISPR-
Cas-mediated immunity and increased sm-mediated immunity
(Figure 3A; F2,15 = 81.4, p < 0.0001). Evolution of sm further
increased when adding 109 pfu NTf at every daily transfer (Fig-
ure S2A; F1,10 = 11.98, p = 0.006). Finally, when infected with 10
7
pfu NTf, the WT strain evolved higher levels of sm-mediated
immunity when grown in 60 ml volume (high phage density)
compared to 6 ml (low phage density, but same number of
phages) (Figure 3B; F1,10 = 25.2, p = 0.0005; Figure S2B;
F1,10 = 12.02, p = 0.006). These data clearly show that infection
risk directly impacts the relative investment in constitutive and
inducible defenses.
We next measured the relative fitness associated with either
immunity mechanism by competing the WT strain against a sm
mutant in the presence of Tf (targeted phage; DMS3mvir), which
is targeted by the WT CRISPR-Cas system (i.e., both strains
are resistant) [26]. An increase in the frequency of one bacterial
strain over another serves as a direct measure of relative fitness.
In agreement with the data above, CRISPR-Cas-mediated
immunity provided a fitness advantage over sm-mediated
immunity when phage exposure was low (relative fitness > 1
upon infection with 104 and 107 pfu Tf), and vice versa when
exposure was high (relative fitness < 1 upon infection with 109
pfu Tf) (Figure 3C; T5 = 5.98, T5 = 11.52, T5 = 430; p < 0.005 in
all cases; Figure S2C).
There are three possible causes for the competitive disadvan-
tage of CRISPR-Cas versus surface modification at high phage
exposure: CRISPR-Cas could (1) provide partial immunity, (2)
be overcome more readily by phage evolution, or (3) be asso-
ciated with greater fitness costs than constitutive immunity, as
assumed in our model. We first examined whether differences
exist in the associated resistance levels by exposing bacteria
with the two types of immunity to high concentrations of phage.
In agreement with the previously reported high survival rates
upon phage exposure of CRISPR immune bacteria [33], we did
not detect any mortality in either case (Figure S2D), which sug-
gested that the immunity levels were not different. Although we
cannot exclude the possibility that differences in mortality rates
exist that fall within the error of the method, further experiments
suggest that partial immunity is unlikely to explain our results.
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Figure 2. Molecular Analysis of Spacer Acquisition
(A–C) PCR-based analysis of the number of spacers acquired by WT in CRISPR1 and CRISPR2 at 3 and 7 dpi with NTf.
(D) Mapping of protospacer locations on either strand of the NTf genome. Of the acquired spacers, 67% ± 8% (3 dpi) and 59% ± 11% (7 dpi) target the negative
strand of the phage, revealing a strand bias at 3 dpi (T5 = 4.14; p = 0.0089), but not at 7 dpi (T5 = 1.50; p = 0.19).
(E) Weblogo of protospacers and 15 bp flanking sequence reveals a protospacer-adjacent motif (PAM), generated using the WebLogo online software (http://
weblogo.berkeley.edu). Bacteria were grown in M9.
See also Figure S2.
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Figure 3. Selection for Constitutive and Inducible Defenses Depends on Parasite Exposure
(A) Fraction of WT that acquired sm-mediated immunity and CRISPR-Cas-mediated immunity at 3 dpi with varying pfu NTf as indicated (n = 6 in all treatments).
(B) Fraction of WT that acquired sm-mediated immunity and CRISPR-Cas-mediated immunity at 3 dpi upon exposure to 107 pfu NTf while grown in 6 ml
(low phage density) or 60 ml (high phage density) (n = 6 in all treatments).
(C) Relative fitness of WT after competing 3 days with sm mutant in the presence of varying pfu Tf, as indicated (n = 6 in all treatments).
Error bars correspond to 95% CIs. Bacteria were grown in M9. See also Figures S2 and S3.CRISPR-mediated immunity led to a 2-fold reduction in phage
titers after 2 hr (Figure S2E), along with a latent period of
80 min and a phage burst size of approximately 88 ± 8
(data not shown), suggesting that at least 99.4% of the bacteria
with CRISPR-mediated immunity are phage resistant (fraction of
phage present after a single infection round = burst size 3 frac-
tion of sensitive bacteria).
As a result of the sequence specificity of CRISPR-Cas-
mediated immunity, phages can readily evolve to overcome
this type of immunity [33, 34]. As genetic diversity increases
with the phage population size, this could contribute to reduced
fitness associated with CRISPR-Cas at high phage exposure.
Phages that carry point mutations that result in escape from
CRISPR-Cas could indeed be readily detected (Figure S2F),
while we could not detect pili-binding phages that overcome
sm. To examine this in detail, we performed competition exper-
iments between smmutants and CRISPR-Cas-immune bacteria
that have multiple spacers targeting multiple Tf loci (bacterio-
phage-insensitive mutant 1 [BIM1] and BIM2; Table S1).
Because multiple spacers of BIM1 and BIM2 target Tf (two
and three spacers, respectively), the phage has a reduced prob-
ability of escaping the immune response by mutation. Crucially,
we found that CRISPR-Cas-mediated immunity was associated
with a fitness disadvantage (relative fitness < 1) when exposed to
109 pfu Tf, regardless of the number of target loci (Figure S2G
[competition in M9]: WT, T5 = 466; BIM1, T5 = 11.7; BIM2, T5 =
11.6; p < 0.0001 in all cases; Figure S2H [competition in LB]:
WT, T5 = 63.5; BIM1, T5 = 21.5; BIM2, T5 = 8.4; p < 0.0001 in
all cases), and phage escaping BIM1 and BIM2 could not be
detected (data not shown). This, along with the data shown in
Figure 3B, indicates that under these conditions the differential
evolution of CRISPR-Cas versus sm is primarily driven by phage
exposure rather than by phage genetic diversity.
Next, we examined whether sm and CRISPR-Cas are asso-
ciated with constitutive and inducible costs of immunity, as1046 Current Biology 25, 1043–1049, April 20, 2015 ª2015 Elsevier Lassumed in the model. To examine whether sm is associated
with a constitutive fitness cost, we competed two independent
sm mutants (sm and sm2; Figures S3A and S3B) against WT
P. aeruginosa PA14. In agreement with previous studies [35],
sm (loss of the pilus, the phage receptor) was associated with
a fitness cost (relative fitness WT > 1) in the absence of phage
(constitutive cost of immunity; Figures 4A and S3C; sm, T5 =
4.99; sm2, T4 = 9.31; p < 0.005 in both cases). Nutrient availability
can directly impact on the cost associated with immunity [36],
suggesting that the observed CRISPR evolution under nutrient-
limited conditions could be purely resource driven. However,
we found that the sm-associated constitutive cost was indepen-
dent of resource availability (M9 versus LB) (Figure S3D; sm,
F1,10 = 1.76; sm2, F1,10 = 0.36; p > 0.20 in both cases).
The inducible cost associated with CRISPR-Cas-mediated
immunity was apparent from our data showing that the relative
fitness of WT versus sm decreases with increasing phage expo-
sure (Figures 3C, S3E, and S3F; Kruskal-Wallis Test, p < 0.005
in both cases); this is because the inducible cost increases
with increasing phage density due to CRISPR-Cas being elicited
more frequently. By contrast, we found no constitutive cost of
CRISPR-Cas-mediated immunity. When the WT P. aeruginosa
strain was competed in the absence of phage against a knockout
mutant (CRISPR-KO; P. aeruginosa csy3::lacZ, carrying a non-
functional CRISPR-Cas system [26]), we found that the WT and
CRISPR-KO strains had a similar fitness (Figure 4B; relative
fitness = 1 T5 = 1.87; p = 0.12 at 5 days), showing that a functional
CRISPR-Cas immune pathway has no detectable fitness cost
when parasites are absent. To examine the fitness conse-
quences of encoding cas genes andCRISPR loci on the genome,
we also competed the CRISPR-KO strain against an isogenic
strain from which the entire CRISPR-Cas system has been
deleted (P. aeruginosa DCRISPR-Cas [29]). Surprisingly, the
DCRISPR-Cas strain had a lower fitness (relative fitness < 1)
than the P. aeruginosa csy3::lacZ strain (Figure S3G; T5 = 38.3;td All rights reserved
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Figure 4. Surface Modification and CRISPR-Cas Are Associated
with a Constitutive and Inducible Cost of Immunity
(A) Relative fitness ofWT after competing 1 day with smmutant in the presence
or absence of phage as indicated (n = 6 for each treatment).
(B) Relative fitness of WT after competition of 1, 3, and 5 days with the
CRISPR-KO strain in the absence of phage (n = 6 at each time point).
Error bars correspond to 95% CIs. Bacteria were grown in LB. See also
Figure S4.p < 0.0001 at 5 days), which indicates that components of
CRISPR-Cas provide a fitness benefit in the absence of phage.
Perhaps P. aeruginosa PA14 CRISPR-Cas functions in pro-
cesses other than immunity, akin to the CRISPR loci and cas
genes of other bacterial species [37]. Taken together, our data
show that sm and CRISPR-Cas are associated with constitutive
and inducible costs of immunity.
Our results suggest that the most likely cause for the cost of
immunity associated with CRISPR-Cas is either an increase in
mortality rate or reduced replication. Increased mortality could
result from autoimmunity [38–40]. In addition, spacer acquisition
requires opening of the bacterial genome (reviewed in [11]) and
erratic incorporation events are potentially lethal. The high
number of spacer duplication events that we observed suggests
that this step may be error prone (Table S1 and data not shown).
Reduced replication rates could result from resources being
allocated to defense that would otherwise be invested in repli-
cation. The reason why surface modification is costly is more
intuitive since phage receptors are often important fitness
determinants of bacteria [41]. Pili, the phage receptors in our
experimental system, are important for bacterial motility [42]
and biofilm formation [43]. Loss of pili has a clearly detectable
cost in a natural environment, soil (data not shown). Although
motility and biofilm formation are not expected to be important
in an in vitro laboratory environment, our fitness analyses show
that bacteria lacking pili suffered a significant competitive cost.
In nature, high parasite densities may contribute to the
existence of non-functional or degenerated CRISPR-Cas
systems. This may explain, along with the suggestion that the
CRISPR-Cas system is less effective in the face of rapidly
evolving viruses, why half of the bacteria lack CRISPR-Cas,
whereas the system is almost ubiquitous among Archaea,
which typically have lower population densities and less expo-
sure to viruses [44]. Indeed, our study shows that carrying aCurrent Biology 25, 104functional CRISPR-Cas system provides a selective advantage
under nutrient-limited conditions in the presence of NTf (relative
fitness > 1; Figure S4A; 104 pfu, T5 = 5.0; 10
7 pfu, T5 = 6.7;
109 pfu, T5 = 4.7; p < 0.006), but not under nutrient-rich condi-
tions (relative fitness = 1; Figure S4B; T5 = 0.44; p = 0.67). Our
findings also help to explain the apparent discrepancy between
laboratory studies and correlational studies of natural popula-
tions. The latter are typically associated with lower bacterial
and phage densities and typically report highly diverse CRISPR
loci that are consistent with a key role in conferring phage
immunity [21, 45, 46]. By contrast, the predominantly reported
mechanism of evolving phage immunity under (nutrient-rich)
laboratory conditions is by modification or masking of surface
receptors [41], even when a CRISPR-Cas adaptive immune
system is present [26] and despite the large competitive cost
generally associated with surface modification [10, 35].
More generally, the theory and the data together suggest
that parasite exposure is likely to be a key factor in driving the
evolution of constitutive and inducible defenses in nature. This
suggests that organisms living together in large populations
or parasite-rich conditions are more likely to evolve constitutive
defenses, whereas low-parasite conditions select for inducible
defenses. Given that most species have both types of defenses,
constitutive defenses are likely to be directed at the more
abundant parasite species, while inducible defenses protect
against the rarer parasites. It will be fascinating to see whether
changes in parasite abundance can explain the observed evolu-
tion of constitutive defense from inducible defense [2], and vice
versa [47].SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.cub.2015.01.065.
AUTHOR CONTRIBUTIONS
E.R.W., S.v.H., and A. Buckling designed experiments. E.R.W., S.v.H., B.M.,
S.O.-B., and J.M.B. performed the experiments. A. Best and M.B. performed
the theoretical analyses. E.R.W., S.v.H., M.B., and A. Buckling analyzed the
data and wrote the manuscript. J.B.-D. and A.D. supplied phages and bacte-
rial strains and provided feedback throughout the project.
ACKNOWLEDGMENTS
The authors wish to thank Adela Lujan for her help in performing the
motility assays. E.R.W. received funding from the People Programme (Marie
Curie Actions) of the European Union’s Seventh Framework Programme
(FP7/2007-2013) under REA grant agreement number 327606. We also
acknowledge the NERC (NE/J009784/1), BBSRC, Royal Society, Leverhulme
Trust, and AXA Research Fund for funding.
Received: October 20, 2014
Revised: January 9, 2015
Accepted: January 28, 2015
Published: March 12, 2015
REFERENCES
1. Tollrian, R., and Harvell, C.D. (1999). The Ecology and Evolution of
Inducible Defenses, First Edition. (Princeton: Princeton University Press).3–1049, April 20, 2015 ª2015 Elsevier Ltd All rights reserved 1047
2. Heil, M., Greiner, S., Meimberg, H., Kru¨ger, R., Noyer, J.L., Heubl, G.,
Linsenmair, K.E., and Boland, W. (2004). Evolutionary change from
induced to constitutive expression of an indirect plant resistance. Nature
430, 205–208.
3. Todesco, M., Balasubramanian, S., Hu, T.T., Traw, M.B., Horton, M.,
Epple, P., Kuhns, C., Sureshkumar, S., Schwartz, C., Lanz, C., et al.
(2010). Natural allelic variation underlying a major fitness trade-off in
Arabidopsis thaliana. Nature 465, 632–636.
4. Kraaijeveld, A.R., and Godfray, H.C. (1997). Trade-off between parasitoid
resistance and larval competitive ability in Drosophila melanogaster.
Nature 389, 278–280.
5. Boots, M., and Begon, M. (1993). Trade-offs with resistance to a granu-
losis virus in the Indian meal moth, examined by a laboratory evolution
experiment. Funct. Ecol. 7, 528–534.
6. Moret, Y., and Schmid-Hempel, P. (2000). Survival for immunity: the price
of immune system activation for bumblebee workers. Science 290, 1166–
1168.
7. Long, G.H., and Boots, M. (2011). How can immunopathology shape
the evolution of parasite virulence? Trends Parasitol. 27, 300–305.
8. Labrie, S.J., Samson, J.E., and Moineau, S. (2010). Bacteriophage resis-
tance mechanisms. Nat. Rev. Microbiol. 8, 317–327.
9. Westra, E.R., Swarts, D.C., Staals, R.H., Jore, M.M., Brouns, S.J., and van
der Oost, J. (2012). The CRISPRs, they are a-changin’: how prokaryotes
generate adaptive immunity. Annu. Rev. Genet. 46, 311–339.
10. Lenski, R.E. (1988). Variation in competitive fitness among mutants resis-
tant to virus T4. Evolution 42, 425–432.
11. van der Oost, J., Westra, E.R., Jackson, R.N., and Wiedenheft, B. (2014).
Unravelling the structural and mechanistic basis of CRISPR-Cas systems.
Nat. Rev. Microbiol. 12, 479–492.
12. Quax, T.E., Voet, M., Sismeiro, O., Dillies, M.A., Jagla, B., Coppe´e, J.Y.,
Sezonov, G., Forterre, P., van der Oost, J., Lavigne, R., and Prangishvili,
D. (2013). Massive activation of archaeal defense genes during viral infec-
tion. J. Virol. 87, 8419–8428.
13. Agari, Y., Sakamoto, K., Tamakoshi, M., Oshima, T., Kuramitsu, S., and
Shinkai, A. (2010). Transcription profile of Thermus thermophilus
CRISPR systems after phage infection. J. Mol. Biol. 395, 270–281.
14. Young, J.C., Dill, B.D., Pan, C., Hettich, R.L., Banfield, J.F., Shah, M.,
Fremaux, C., Horvath, P., Barrangou, R., and Verberkmoes, N.C. (2012).
Phage-induced expression of CRISPR-associated proteins is revealed
by shotgun proteomics in Streptococcus thermophilus. PLoS ONE 7,
e38077.
15. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P.,
Moineau, S., Romero, D.A., and Horvath, P. (2007). CRISPR provides ac-
quired resistance against viruses in prokaryotes. Science 315, 1709–1712.
16. Jore, M.M., Lundgren, M., van Duijn, E., Bultema, J.B., Westra, E.R.,
Waghmare, S.P., Wiedenheft, B., Pul, U., Wurm, R., Wagner, R., et al.
(2011). Structural basis for CRISPR RNA-guided DNA recognition by
Cascade. Nat. Struct. Mol. Biol. 18, 529–536.
17. Hale, C.R., Zhao, P., Olson, S., Duff, M.O., Graveley, B.R., Wells, L., Terns,
R.M., and Terns, M.P. (2009). RNA-guided RNA cleavage by a CRISPR
RNA-Cas protein complex. Cell 139, 945–956.
18. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., and
Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonu-
clease in adaptive bacterial immunity. Science 337, 816–821.
19. Westra, E.R., van Erp, P.B., Ku¨nne, T., Wong, S.P., Staals, R.H., Seegers,
C.L., Bollen, S., Jore, M.M., Semenova, E., Severinov, K., et al. (2012).
CRISPR immunity relies on the consecutive binding and degradation of
negatively supercoiled invader DNA by Cascade and Cas3. Mol. Cell 46,
595–605.
20. Garneau, J.E., Dupuis, M.E`., Villion, M., Romero, D.A., Barrangou, R.,
Boyaval, P., Fremaux, C., Horvath, P., Magada´n, A.H., and Moineau, S.
(2010). The CRISPR/Cas bacterial immune system cleaves bacteriophage
and plasmid DNA. Nature 468, 67–71.1048 Current Biology 25, 1043–1049, April 20, 2015 ª2015 Elsevier L21. Andersson, A.F., and Banfield, J.F. (2008). Virus population dynamics and
acquired virus resistance in natural microbial communities. Science 320,
1047–1050.
22. Avrani, S., Wurtzel, O., Sharon, I., Sorek, R., and Lindell, D. (2011).
Genomic island variability facilitates Prochlorococcus-virus coexistence.
Nature 474, 604–608.
23. Shudo, E., and Iwasa, Y. (2001). Inducible defense against pathogens and
parasites: optimal choice among multiple options. J. Theor. Biol. 209,
233–247.
24. Hamilton, R., Siva-Jothy, M., and Boots, M. (2008). Two arms are better
than one: parasite variation leads to combined inducible and constitutive
innate immune responses. Proc. Biol. Sci. 275, 937–945.
25. Makarova, K.S., Haft, D.H., Barrangou, R., Brouns, S.J., Charpentier, E.,
Horvath, P., Moineau, S., Mojica, F.J., Wolf, Y.I., Yakunin, A.F., et al.
(2011). Evolution and classification of the CRISPR-Cas systems. Nat.
Rev. Microbiol. 9, 467–477.
26. Cady, K.C., Bondy-Denomy, J., Heussler, G.E., Davidson, A.R., and
O’Toole, G.A. (2012). The CRISPR/Cas adaptive immune system of
Pseudomonas aeruginosa mediates resistance to naturally occurring
and engineered phages. J. Bacteriol. 194, 5728–5738.
27. Budzik, J.M., Rosche, W.A., Rietsch, A., and O’Toole, G.A. (2004).
Isolation and characterization of a generalized transducing phage for
Pseudomonas aeruginosa strains PAO1 and PA14. J. Bacteriol. 186,
3270–3273.
28. Richter, C., Dy, R.L., McKenzie, R.E., Watson, B.N., Taylor, C., Chang,
J.T., McNeil, M.B., Staals, R.H., and Fineran, P.C. (2014). Priming in the
Type I-F CRISPR-Cas system triggers strand-independent spacer acqui-
sition, bi-directionally from the primed protospacer. Nucleic Acids Res. 42,
8516–8526.
29. Cady, K.C., and O’Toole, G.A. (2011). Non-identity-mediated CRISPR-
bacteriophage interaction mediated via the Csy and Cas3 proteins.
J. Bacteriol. 193, 3433–3445.
30. Mojica, F.J., Dı´ez-Villasen˜or, C., Garcı´a-Martı´nez, J., and Almendros, C.
(2009). Short motif sequences determine the targets of the prokaryotic
CRISPR defence system. Microbiology 155, 733–740.
31. Yosef, I., Goren, M.G., and Qimron, U. (2012). Proteins and DNA elements
essential for the CRISPR adaptation process in Escherichia coli. Nucleic
Acids Res. 40, 5569–5576.
32. Swarts, D.C., Mosterd, C., van Passel, M.W., and Brouns, S.J. (2012).
CRISPR interference directs strand specific spacer acquisition. PLoS
ONE 7, e35888.
33. Deveau, H., Barrangou, R., Garneau, J.E., Labonte´, J., Fremaux, C.,
Boyaval, P., Romero, D.A., Horvath, P., and Moineau, S. (2008). Phage
response to CRISPR-encoded resistance in Streptococcus thermophilus.
J. Bacteriol. 190, 1390–1400.
34. Semenova, E., Jore, M.M., Datsenko, K.A., Semenova, A., Westra, E.R.,
Wanner, B., van der Oost, J., Brouns, S.J., and Severinov, K. (2011).
Interference by clustered regularly interspaced short palindromic repeat
(CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci.
USA 108, 10098–10103.
35. Brockhurst, M.A., Buckling, A., and Rainey, P.B. (2005). The
effect of a bacteriophage on diversification of the opportunistic
bacterial pathogen, Pseudomonas aeruginosa. Proc. Biol. Sci. 272,
1385–1391.
36. Go´mez, P., and Buckling, A. (2011). Bacteria-phage antagonistic coevolu-
tion in soil. Science 332, 106–109.
37. Westra, E.R., Buckling, A., and Fineran, P.C. (2014). CRISPR-Cas sys-
tems: beyond adaptive immunity. Nat. Rev. Microbiol. 12, 317–326.
38. Stern, A., Keren, L., Wurtzel, O., Amitai, G., and Sorek, R. (2010). Self-
targeting by CRISPR: gene regulation or autoimmunity? Trends Genet.
26, 335–340.
39. Vercoe, R.B., Chang, J.T., Dy, R.L., Taylor, C., Gristwood, T., Clulow, J.S.,
Richter, C., Przybilski, R., Pitman, A.R., and Fineran, P.C. (2013). Cytotoxic
chromosomal targeting by CRISPR/Cas systems can reshape bacterialtd All rights reserved
genomes and expel or remodel pathogenicity islands. PLoS Genet. 9,
e1003454.
40. Edgar, R., and Qimron, U. (2010). The Escherichia coli CRISPR system
protects from l lysogenization, lysogens, and prophage induction.
J. Bacteriol. 192, 6291–6294.
41. Buckling, A., and Brockhurst, M. (2012). Bacteria-virus coevolution. Adv.
Exp. Med. Biol. 751, 347–370.
42. Mattick, J.S. (2002). Type IV pili and twitching motility. Annu. Rev.
Microbiol. 56, 289–314.
43. O’Toole, G.A., and Kolter, R. (1998). Flagellar and twitching motility are
necessary for Pseudomonas aeruginosa biofilm development. Mol.
Microbiol. 30, 295–304.Current Biology 25, 10444. Weinberger, A.D., Wolf, Y.I., Lobkovsky, A.E., Gilmore, M.S., and Koonin,
E.V. (2012). Viral diversity threshold for adaptive immunity in prokaryotes.
MBio 3, e00456-12.
45. Tyson, G.W., and Banfield, J.F. (2008). Rapidly evolving CRISPRs impli-
cated in acquired resistance of microorganisms to viruses. Environ.
Microbiol. 10, 200–207.
46. Emerson, J.B., Andrade, K., Thomas, B.C., Norman, A., Allen, E.E.,
Heidelberg, K.B., and Banfield, J.F. (2013). Virus-host and CRISPR dy-
namics in Archaea-dominated hypersaline Lake Tyrrell, Victoria,
Australia. Archaea 2013, 370871.
47. Thaler, J.S., and Karban, R. (1997). A phylogenetic reconstruction of con-
stitutive and induced resistance in Gossypium. Am. Nat. 149, 1139–1146.3–1049, April 20, 2015 ª2015 Elsevier Ltd All rights reserved 1049
